跳至主要内容
临床试验/KCT0000594
KCT0000594招募中未知

A randomized, Single center, double blind, parallel, placebo-controlled clinical study of efficacy and safety of Chung A Won in Women’s patients with osteoporosis

Cheonan Korean Medicine Hospital of Daejeon University0 个研究点目标入组 106 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
50(Year) 至 o Limit(—)
性别
Female

入选标准

  • Female more than 50 years old in osteoporosis

排除标准

  • 1)Wash out peroid: using agents more than 3 months against osteoporosis
  • 2)Subject who takes drugs that may affect the clinical trials (Corticosteroids, anticonvulsants, tranquilizers, antidepressants, hypnotic, diuretic)
  • 3)Subject who has a chronic liver disease, thyroid disease and chronic renal disease
  • 4)Subject who is chronic alcoholics and undernourished
  • 5)Other conditions were not suitable in study : Severe physical defects mental defects
  • 6)Pregnant woman
  • 7)Subject who is not calibrated hypercalcemia/hypocalcemia
  • 8) Secondary osteoporosis : Subject who takes drugs(Glucocorticoid, Diabetes Medications)
  • 9) Subject who has 60% more fracture risk in FRAX(WHO fracture risk assessment tool)

研究者

发起方
Cheonan Korean Medicine Hospital of Daejeon University

相似试验